These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21654410)

  • 1. Engineered nanomaterials: learning from the past, planning for the future.
    Kreider T; Halperin W
    J Occup Environ Med; 2011 Jun; 53(6 Suppl):S108-12. PubMed ID: 21654410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomaterials and worker health: medical surveillance, exposure registries, and epidemiologic research.
    Schulte PA; Trout DB
    J Occup Environ Med; 2011 Jun; 53(6 Suppl):S3-7. PubMed ID: 21654413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomaterial risk assessment and management experiences related to worker health under the Toxic Substances Control Act.
    Sayre P; Prothero S; Alwood J
    J Occup Environ Med; 2011 Jun; 53(6 Suppl):S98-102. PubMed ID: 21654427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protecting workers from risks associated with nanomaterials: part II, best practices in risk management.
    Kreider ML; Burns AM; Derose GH; Panko JM
    Occup Health Saf; 2013 Sep; 82(9):20, 22, 24. PubMed ID: 24260937
    [No Abstract]   [Full Text] [Related]  

  • 5. Protecting workers from risks associated with nanomaterials: Part I, Exposure assessment.
    Kreider ML; Burns AM; Derose GH; Panko JM
    Occup Health Saf; 2013 Jul; 82(7):90-1, 94. PubMed ID: 23951851
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of a French epidemiological surveillance system of workers producing or handling engineered nanomaterials in the workplace.
    Boutou-Kempf O; Marchand JL; Radauceanu A; Witschger O; Imbernon E;
    J Occup Environ Med; 2011 Jun; 53(6 Suppl):S103-7. PubMed ID: 21654409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International landscape of limits and recommendations for occupational exposure to engineered nanomaterials.
    Rodríguez-Ibarra C; Déciga-Alcaraz A; Ispanixtlahuatl-Meráz O; Medina-Reyes EI; Delgado-Buenrostro NL; Chirino YI
    Toxicol Lett; 2020 Apr; 322():111-119. PubMed ID: 31981686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health and safety implications of occupational exposure to engineered nanomaterials.
    Stebounova LV; Morgan H; Grassian VH; Brenner S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(3):310-21. PubMed ID: 22131295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Health risks of engineered nanomaterials and nanotechnologies].
    Savolainen K; Vainio H
    Duodecim; 2011; 127(11):1097-104. PubMed ID: 21755801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Achieving Control of Occupational Exposures to Engineered Nanomaterials.
    Juric A; Meldrum R; Liberda EN
    J Occup Environ Hyg; 2015; 12(8):501-8. PubMed ID: 25635953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing adoption of precautionary risk management guidance for nanomaterials, an emerging occupational hazard.
    Schubauer-Berigan MK; Dahm MM; Schulte PA; Hodson L; Geraci CL
    J Occup Environ Hyg; 2015; 12(1):69-75. PubMed ID: 25093252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Institute for Occupational Safety and Health Nanomaterials and Worker Health Conference--medical surveillance session summary report.
    Fischman M; Storey E; McCunney RJ; Kosnett M
    J Occup Environ Med; 2011 Jun; 53(6 Suppl):S35-7. PubMed ID: 21606850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers of susceptibility: State of the art and implications for occupational exposure to engineered nanomaterials.
    Iavicoli I; Leso V; Schulte PA
    Toxicol Appl Pharmacol; 2016 May; 299():112-24. PubMed ID: 26724381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of nanomaterials safety in research environment.
    Groso A; Petri-Fink A; Magrez A; Riediker M; Meyer T
    Part Fibre Toxicol; 2010 Dec; 7():40. PubMed ID: 21143952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding workplace processes and factors that influence exposures to engineered nanomaterials.
    Woskie SR; Bello D; Virji MA; Stefaniak AB
    Int J Occup Environ Health; 2010; 16(4):365-77. PubMed ID: 21222381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Workplace exposure to engineered nanomaterials: the Italian path for the definition of occupational health and safety policies.
    Mirabile M; Boccuni F; Gagliardi D; Rondinone BM; Iavicoli S
    Health Policy; 2014 Jul; 117(1):128-34. PubMed ID: 24582490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difficulties in establishing regulations for engineered nanomaterials and considerations for policy makers: avoiding an unbalance between benefits and risks.
    Garduño-Balderas LG; Urrutia-Ortega IM; Medina-Reyes EI; Chirino YI
    J Appl Toxicol; 2015 Oct; 35(10):1073-85. PubMed ID: 26046543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Workplace practices for engineered nanomaterial manufacturers.
    Woskie S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(6):685-92. PubMed ID: 20593453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk assessment and risk management of nanomaterials in the workplace: translating research to practice.
    Kuempel ED; Geraci CL; Schulte PA
    Ann Occup Hyg; 2012 Jul; 56(5):491-505. PubMed ID: 22752094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the occupational, consumer and environmental exposure to engineered nanomaterials used in 10 technology sectors.
    Nowack B; Brouwer C; Geertsma RE; Heugens EH; Ross BL; Toufektsian MC; Wijnhoven SW; Aitken RJ
    Nanotoxicology; 2013 Sep; 7(6):1152-6. PubMed ID: 22783888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.